Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Return on Invested Capital (2018 - 2025)

Abvc Biopharma (ABVC) has disclosed Return on Invested Capital for 8 consecutive years, with 0.58% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital rose 159.0% year-over-year to 0.58%, compared with a TTM value of 0.58% through Dec 2025, up 159.0%, and an annual FY2025 reading of 1.03%, up 116.0% over the prior year.
  • Return on Invested Capital was 0.58% for Q4 2025 at Abvc Biopharma, down from 0.48% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.48% in Q3 2025 and bottomed at 7.67% in Q2 2023.
  • Average Return on Invested Capital over 5 years is 2.45%, with a median of 2.03% recorded in 2022.
  • Peak annual rise in Return on Invested Capital hit 738bps in 2021, while the deepest fall reached -930bps in 2021.
  • Year by year, Return on Invested Capital stood at 1.47% in 2021, then plummeted by -92bps to 2.82% in 2022, then surged by 55bps to 1.28% in 2023, then tumbled by -70bps to 2.17% in 2024, then surged by 73bps to 0.58% in 2025.
  • Business Quant data shows Return on Invested Capital for ABVC at 0.58% in Q4 2025, 0.48% in Q3 2025, and 2.17% in Q4 2024.